INT99966

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.37
First Reported 2001
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 13
Total Number 13
Disease Relevance 13.32
Pain Relevance 0.98

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
blood 2
eyes 2
cavity 2
NARFL (Homo sapiens)
Pain Link Frequency Relevance Heat
antagonist 23 98.24 Very High Very High Very High
beta blocker 19 96.04 Very High Very High Very High
sSRI 43 92.88 High High
alcohol 7 87.68 High High
Pain 15 79.08 Quite High
fibrosis 4 78.00 Quite High
Inflammation 14 76.32 Quite High
ischemia 19 75.96 Quite High
Paracetamol 2 75.60 Quite High
cva 13 70.84 Quite High
Disease Link Frequency Relevance Heat
Ocular Hypertension 855 100.00 Very High Very High Very High
Glaucoma 391 99.12 Very High Very High Very High
Infection 2 97.40 Very High Very High Very High
Herpes Simplex Virus Infection 2 97.00 Very High Very High Very High
Congenital Anomalies 6 93.92 High High
Eczema 1 91.56 High High
Pressure And Volume Under Development 12 91.32 High High
Cold Sores 3 91.12 High High
Hyponatremia 5 91.00 High High
Diabetes Mellitus 16 90.28 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Supine 2 IOP (31 +/- 2 mmHg) decreased in comparison with prone 2 IOP (P < 0.05) but was relatively elevated in comparison with supine 1 and baseline (P < 0.05).
Negative_regulation (decreased) of Positive_regulation (elevated) of IOP
1) Confidence 0.37 Published 2001 Journal Anesthesiology Section Body Doc Link 11748391 Disease Relevance 0.05 Pain Relevance 0
The persistence of IOP elevation despite cessation of steroid treatment has been known for a long time (Spaeth et al 1977).
Negative_regulation (persistence) of Positive_regulation (elevation) of IOP associated with ocular hypertension
2) Confidence 0.35 Published 2008 Journal Clinical ophthalmology (Auckland, N.Z.) Section Body Doc Link PMC2698684 Disease Relevance 1.23 Pain Relevance 0
Important IOP increases were first observed in the first week postinjection and then most frequently in the first month; thereafter the levels gradually declined due to the effect of the topical treatments and also probably to the clearance of triamcinolone from the vitreous cavity with time.
Negative_regulation (declined) of Positive_regulation (increases) of IOP in cavity associated with ocular hypertension
3) Confidence 0.35 Published 2008 Journal Clinical ophthalmology (Auckland, N.Z.) Section Body Doc Link PMC2698684 Disease Relevance 1.08 Pain Relevance 0.04
Most of the oxybuprocaine subjects presented with an IOP change within ±2 mmHg (of the initial IOP) after instillation of the eyedrops, with approximately 87% (two minutes and five minutes post eyedrop instillation) showing an IOP change that ranged from +1 mmHg to ?
Negative_regulation (presented) of Positive_regulation (initial) of IOP associated with ocular hypertension
4) Confidence 0.23 Published 2007 Journal Clinical ophthalmology (Auckland, N.Z.) Section Body Doc Link PMC2701119 Disease Relevance 1.23 Pain Relevance 0
In combination, they are approved to reduce elevated IOP in patients with open-angle glaucoma or ocular hypertension and with insufficient IOP response to beta-blockers monotherapy (Cosopt® online 2007).
Negative_regulation (reduce) of Positive_regulation (elevated) of IOP associated with beta blocker, glaucoma and ocular hypertension
5) Confidence 0.21 Published 2008 Journal Clinical ophthalmology (Auckland, N.Z.) Section Body Doc Link PMC2693974 Disease Relevance 0.73 Pain Relevance 0.05
Masuda et al.7 reported that Argon laser trabeculoplasty successfully controlled the IOP elevation in exfoliative glaucoma patients showing intradialytic IOP elevation, while Choong et al.6 reported that bilateral IOP elevation after hemodialysis stabilized with topical ?
Negative_regulation (reported) of Positive_regulation (elevation) of IOP associated with glaucoma and ocular hypertension
6) Confidence 0.18 Published 2006 Journal Korean Journal of Ophthalmology : KJO Section Body Doc Link PMC2908824 Disease Relevance 1.57 Pain Relevance 0.11
A diagnosis of left angle-closure glaucoma was made and medications were commenced to reduce the elevated IOP.
Negative_regulation (reduce) of Positive_regulation (elevated) of IOP associated with glaucoma
7) Confidence 0.16 Published 2005 Journal BMC Ophthalmol Section Body Doc Link PMC1262727 Disease Relevance 0.53 Pain Relevance 0.32
Rainer et al (2005) reported significant IOP increases during the first 24 hours, peaking at 1 hour after surgery (13.4 ± 9.4 mm Hg), in eyes that were operated with Viscoat®.
Negative_regulation (reported) of Positive_regulation (increases) of IOP in eyes associated with ocular hypertension
8) Confidence 0.14 Published 2008 Journal Clinical ophthalmology (Auckland, N.Z.) Section Body Doc Link PMC2698691 Disease Relevance 0.96 Pain Relevance 0
1.31, 0.16 mmHg) in the Europe/Israel study, showing that the dorzolamide–timolol fixed combination therapy was equally effective at lowering IOP as the latanoprost 0.005% therapy.32
Negative_regulation (effective) of Positive_regulation (lowering) of IOP associated with ocular hypertension
9) Confidence 0.09 Published 2010 Journal Clinical Ophthalmology (Auckland, N.Z.) Section Body Doc Link PMC2993108 Disease Relevance 0.77 Pain Relevance 0
In that capacity, OAG progression is not necessarily related to the overall level of blood pressure, but an abnormal vascular reaction to a reduction in blood pressure or increase in IOP during nonwaking hours (Werne et al 2008).
Negative_regulation (reduction) of Positive_regulation (increase) of IOP in blood associated with glaucoma and ocular hypertension
10) Confidence 0.08 Published 2008 Journal Clinical Ophthalmology (Auckland, N.Z.) Section Body Doc Link PMC2699797 Disease Relevance 1.35 Pain Relevance 0.14
This IOP elevation was blocked by the pretreatment with the V(1) receptor antagonist.
Negative_regulation (blocked) of Positive_regulation (elevation) of IOP associated with antagonist and ocular hypertension
11) Confidence 0.06 Published 2008 Journal Current Neuropharmacology Section Body Doc Link PMC2701282 Disease Relevance 1.26 Pain Relevance 0.26
Bimatoprost is effective in reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension.
Negative_regulation (reduction) of Positive_regulation (elevated) of IOP associated with glaucoma and ocular hypertension
12) Confidence 0.06 Published 2007 Journal Clinical ophthalmology (Auckland, N.Z.) Section Body Doc Link PMC2701126 Disease Relevance 1.73 Pain Relevance 0.03
Some published data report Nd:YAG laser iridotomy as an effective therapy in widening
               the drainage angle and reducing elevated IOP in people with primary angle closure
               (Nolan et al 2002; Ahmed 2006).
               
Negative_regulation (reducing) of Positive_regulation (elevated) of IOP associated with ocular hypertension
13) Confidence 0.02 Published 2008 Journal Clinical Ophthalmology (Auckland, N.Z.) Section Body Doc Link PMC2699817 Disease Relevance 0.81 Pain Relevance 0.03

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox